MedTrace Logo

CERENOVUS Neurothrombectomy Devices Registry

NCT03685578 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-06-03

No results posted yet for this study

Summary

A post-market registry evaluating the EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC™ Aspiration Catheter, and CEREGLIDE 71 Intermediate Catheter in acute ischemic stroke patients with confirmed intracranial vessel occlusion.

Conditions

  • Cerebral Stroke

Interventions

DEVICE

EmboTrap® Revascularization Device

EmboTrap® Revascularization Device

DEVICE

CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter

CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter

DEVICE

CEREGLIDE 71 Intermediate Catheter

CEREGLIDE 71 Intermediate Catheter

Sponsors & Collaborators

  • Cerenovus, Part of DePuy Synthes Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Adnan Siddiqui, MD, PhD · University at Buffalo

  • Tommy Andersson, MD, PhD · AZ Groeninge/ Karolinska University Hospital

  • Raul Nogueira, MD · UPMC Stroke Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-28
Primary Completion
2025-02-20
Completion
2025-02-20
FDA Device
Yes

Countries

  • United States
  • Belgium
  • France
  • Germany
  • Israel
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685578 on ClinicalTrials.gov